GO:0086012 membrane depolarization during cardiac muscle cell action potential: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0086012 describes the rapid rise in cardiac muscle cell membrane potential from the negative resting potential toward the positive peak of the action potential.
• The upstroke is driven primarily by voltage-gated sodium channel (Nav1.5, SCN5A) activation, with contributions from L-type calcium current (Cav1.2, CACNA1C) in some cell types.
• Calcium signaling and intracellular calcium cycling are tightly coupled to depolarization and repolarization, influencing contractility and arrhythmogenesis.
• Disruption of depolarization components is linked to atrial fibrillation, ventricular arrhythmias, and inherited channelopathies.
• MicroRNAs and non-canonical regulators such as FGF13 can biophysically modulate cardiac action potential and impulse propagation.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of genes controlling membrane depolarization.
Description
Membrane depolarization during cardiac muscle cell action potential (GO:0086012) is the biological process in which the cardiac muscle cell membrane potential rapidly shifts from its negative resting value toward the positive peak of the action potential. This upstroke phase is essential for excitation-contraction coupling and for the coordinated propagation of electrical impulses through the heart. Researchers study this process to understand normal cardiac rhythm and to identify molecular defects that lead to arrhythmias and heart failure. The depolarization phase is initiated by the opening of voltage-gated ion channels, predominantly sodium channels, which allow a rapid influx of positive charge. In some cardiac cell types, such as atrial and nodal cells, L-type calcium current contributes significantly to the upstroke. Because the action potential waveform determines calcium entry and contractile strength, even subtle changes in depolarization kinetics can have profound physiological consequences. Consequently, GO:0086012 is a focal point for cardiac electrophysiology, channelopathy research, and drug discovery. Understanding its molecular players and regulatory mechanisms is critical for developing targeted therapies for arrhythmias.
membrane depolarization during cardiac muscle cell action potential At A Glance
| GO ID | GO:0086012 |
|---|---|
| GO term | membrane depolarization during cardiac muscle cell action potential |
| Ontology | biological_process |
| Synonym | none |
| Major function | Rapid rise in membrane potential from resting negative to positive peak, enabling excitation-contraction coupling and impulse propagation |
| Key ion channels | Voltage-gated sodium channels (Nav1.5/SCN5A), L-type calcium channels (Cav1.2/CACNA1C) |
| Cellular context | Cardiac muscle cells (cardiomyocytes), including ventricular, atrial, and nodal cells |
| Related processes | Action potential repolarization, calcium signaling, mechano-electric feedback |
| Disease relevance | Arrhythmias, atrial fibrillation, channelopathies, heart failure |
What Is GO:0086012?
GO:0086012 is defined as the process in which cardiac muscle cell membrane potential changes in the depolarizing direction from the negative resting potential towards the positive membrane potential that will be the peak of the action potential. In simpler terms, it is the rapid electrical 'switch-on' phase of a heart muscle cell, where the inside of the cell becomes less negative and then positive, triggering the events that lead to contraction.
Why Is membrane depolarization during cardiac muscle cell action potential Important in Cell Biology?
GO:0086012 is fundamental to cardiac physiology because the depolarization phase determines the timing and amplitude of calcium entry, which in turn controls the strength of each heartbeat. Defects in the ion channels and regulatory proteins that mediate depolarization can cause life-threatening arrhythmias, including atrial fibrillation and ventricular tachycardia. Moreover, depolarization is modulated by mechanical stretch (mechano-electric feedback), microRNAs, and non-canonical regulators, making it a hub for integrative cardiac signaling. Studying this process helps researchers identify therapeutic targets and understand how genetic variants alter cardiac electrical function.
• Depolarization initiates the action potential upstroke, which is required for synchronous cardiac contraction.
• Voltage-gated sodium channel (SCN5A) mutations are linked to Brugada syndrome, long QT syndrome, and conduction defects.
• L-type calcium current contributes to depolarization in atrial and nodal cells and is a target for antiarrhythmic drugs.
• Calcium cycling abnormalities during depolarization can cause alternans and arrhythmias.
• Mechano-electric feedback modulates depolarization and can trigger arrhythmias under mechanical stress.
• MicroRNAs can directly bind ion channels and biophysically modulate the action potential.
• FGF13 regulates impulse propagation independent of voltage-gated sodium channels, revealing non-canonical control.
• Human induced pluripotent stem cell-derived cardiomyocytes model atrial fibrillation-associated electrical remodeling.
• Depolarization defects are central to inherited channelopathies and acquired heart diseases.
• CRISPR editing enables precise testing of gene variants affecting depolarization.
What Happens During membrane depolarization during cardiac muscle cell action potential?
Resting state and channel priming
In simple terms: Before the heart cell fires, it is electrically negative inside, and the ion channels are ready to open.
At rest, cardiac muscle cells maintain a negative membrane potential (approximately -80 to -90 mV) due to the distribution of ions across the membrane and the activity of background potassium channels. Voltage-gated sodium channels (Nav1.5) are closed but primed to open upon depolarization. This resting state is critical because it sets the threshold for the subsequent upstroke.
Initiation of depolarization by sodium influx
In simple terms: A small electrical stimulus opens sodium channels, letting positive sodium ions rush in and making the cell interior more positive.
When a depolarizing stimulus reaches threshold, voltage-gated sodium channels open rapidly, allowing a large influx of sodium ions (INa). This positive feedback loop causes the membrane potential to rise quickly toward the positive peak of the action potential. The sodium current is the primary driver of the upstroke in ventricular and atrial cardiomyocytes.
Contribution of L-type calcium current
In simple terms: In some heart cells, calcium channels also open to help the cell become positive.
In addition to sodium current, L-type calcium current (ICa,L) through Cav1.2 channels contributes to the depolarization phase, especially in nodal and atrial cells where the upstroke is slower. Calcium influx during this phase also triggers calcium release from the sarcoplasmic reticulum, linking electrical excitation to contraction.
Calcium-induced calcium release and excitation-contraction coupling
In simple terms: The calcium that enters during depolarization tells the cell to release more calcium, which makes the heart muscle contract.
The depolarization-induced calcium entry through L-type calcium channels activates ryanodine receptors (RyR2) on the sarcoplasmic reticulum, causing a massive release of calcium into the cytosol. This calcium then binds to troponin C, initiating cross-bridge cycling and contraction. Thus, membrane depolarization is directly coupled to mechanical output.
Modulation by non-canonical regulators and microRNAs
In simple terms: Other molecules, like microRNAs and FGF13, can fine-tune how the cell depolarizes.
Recent studies show that microRNAs can directly bind to ion channels and modulate the action potential biophysically. Additionally, FGF13 regulates cardiomyocyte impulse propagation via connexin-43 trafficking, independent of voltage-gated sodium channels. These findings highlight additional layers of regulation beyond classic ion channels.
Mechano-electric feedback
In simple terms: Mechanical stretch of the heart can change how the cells depolarize, which can sometimes cause arrhythmias.
Mechano-electric feedback refers to the modulation of cardiac electrical activity by mechanical stretch. Stretch-activated channels and other mechanisms can alter the depolarization phase, contributing to arrhythmogenesis under conditions such as volume overload or hypertension.
Key Genes Involved in GO:0086012 membrane depolarization during cardiac muscle cell action potential
The following genes encode ion channels, calcium-handling proteins, and regulatory factors that are experimentally implicated in membrane depolarization during cardiac muscle cell action potential.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SCN5A | Encodes Nav1.5, the primary voltage-gated sodium channel mediating the upstroke | Mutations cause Brugada syndrome, long QT syndrome, and conduction defects |
| CACNA1C | Encodes Cav1.2, the L-type calcium channel alpha-1C subunit | Contributes to depolarization in atrial/nodal cells; target for calcium channel blockers |
| CACNB2 | Encodes the beta-2 subunit of L-type calcium channels | Modulates channel gating and current density; associated with Brugada syndrome |
| RYR2 | Ryanodine receptor 2, mediates calcium release from sarcoplasmic reticulum | Calcium-induced calcium release during excitation-contraction coupling |
| ATP2A2 | SERCA2a, pumps calcium back into sarcoplasmic reticulum | Regulates calcium cycling and relaxation; affects action potential duration |
| FGF13 | Fibroblast growth factor 13, regulates connexin-43 trafficking | Modulates impulse propagation independent of sodium channels |
| GJA1 | Connexin-43, gap junction protein | Required for electrical coupling and impulse propagation |
| KCNQ1 | Potassium channel alpha subunit (IKs) | Affects repolarization and indirectly depolarization; mutations cause long QT syndrome |
| KCNH2 | Potassium channel alpha subunit (IKr) | Repolarization; mutations cause long QT syndrome |
| SCN1B | Sodium channel beta-1 subunit | Modulates Nav1.5 gating; mutations linked to Brugada syndrome |
| SCN2B | Sodium channel beta-2 subunit | Modulates Nav1.5; associated with arrhythmias |
| CALM1 | Calmodulin 1, calcium sensor | Regulates calcium channels and RyR2; mutations cause long QT and CPVT |
| CALM2 | Calmodulin 2 | Similar to CALM1; involved in calcium signaling |
| CALM3 | Calmodulin 3 | Regulates ion channels; mutations linked to cardiac arrhythmias |
| TNNI3 | Troponin I, inhibitory subunit | Regulates contraction downstream of calcium; mutations cause cardiomyopathy |
| TNNT2 | Troponin T, tropomyosin-binding subunit | Contraction regulation; mutations cause hypertrophic cardiomyopathy |
| MYH7 | Beta-myosin heavy chain | Contractile protein; mutations cause cardiomyopathy |
| ACTN2 | Alpha-actinin-2, cytoskeletal protein | Anchors ion channels and receptors at sarcomeres |
How Is membrane depolarization during cardiac muscle cell action potential Regulated?
The depolarization phase of the cardiac action potential is regulated by multiple mechanisms. Voltage-gated sodium channels are modulated by auxiliary beta subunits (SCN1B, SCN2B) and by phosphorylation. L-type calcium channels are regulated by calmodulin and by beta-adrenergic signaling. Intracellular calcium levels and calcium-calmodulin-dependent kinase II (CaMKII) can feedback on ion channels. MicroRNAs can directly bind to ion channels and alter their biophysical properties. Additionally, FGF13 regulates connexin-43 trafficking, affecting impulse propagation. Mechanical stretch can modulate depolarization through mechano-electric feedback. These regulatory layers ensure fine-tuning of cardiac electrical activity.
membrane depolarization during cardiac muscle cell action potential and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SCN5A | Brugada syndrome, long QT syndrome, conduction defects | Knockout or point-mutation knock-in in hiPSC-derived cardiomyocytes |
| CACNA1C | Timothy syndrome, Brugada syndrome | Point mutation knock-in in hiPSC-derived cardiomyocytes |
| RYR2 | Catecholaminergic polymorphic ventricular tachycardia (CPVT) | Knock-in of CPVT mutations in hiPSC-derived cardiomyocytes |
| FGF13 | Impulse propagation defects, arrhythmias | Knockout or overexpression in cardiomyocytes |
| GJA1 | Arrhythmogenic cardiomyopathy, conduction slowing | Knockout in hiPSC-derived cardiomyocytes |
Arrhythmias and channelopathies
Mutations in SCN5A, CACNA1C, and other ion channel genes alter depolarization and cause inherited arrhythmia syndromes such as Brugada syndrome, long QT syndrome, and conduction defects. Atrial fibrillation is associated with electrical remodeling that includes changes in depolarization parameters, as modeled in human induced pluripotent stem cell-derived atrial cardiomyocytes. These disorders highlight the clinical importance of precise depolarization control.
Calcium cycling disorders and alternans
Abnormal intracellular calcium cycling can lead to cardiac alternans, a beat-to-beat oscillation in action potential duration and calcium transient amplitude that predisposes to ventricular arrhythmias. Defects in RyR2 or SERCA2a affect calcium handling and can indirectly alter depolarization and repolarization.
Mechano-electric feedback and stretch-induced arrhythmias
Mechanical stretch of the myocardium can modulate depolarization through mechano-electric feedback, contributing to arrhythmias in conditions such as heart failure and hypertension. This crosstalk between mechanical and electrical function is an active area of research.
Non-canonical regulators in disease
FGF13 has been implicated in impulse propagation defects, and its regulation of connexin-43 trafficking suggests a role in arrhythmogenesis independent of sodium channels. MicroRNAs that modulate ion channels may also contribute to electrical remodeling in disease.
From membrane depolarization during cardiac muscle cell action potential-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SCN5A affect depolarization upstroke? | SCN5A knockout in hiPSC-derived cardiomyocytes or HEK293 cells |
| How does a specific CACNA1C variant alter calcium current? | Point mutation knock-in in hiPSC-derived cardiomyocytes |
| Can a disease-associated FGF13 mutation impair impulse propagation? | Knock-in of patient mutation in hiPSC-derived cardiomyocytes |
| What is the effect of overexpressing a microRNA on action potential? | Overexpression of microRNA in hiPSC-derived cardiomyocytes |
| Does a tagged ion channel show altered trafficking? | Tagged knock-in of SCN5A or CACNA1C in cardiomyocytes |
| Can CRISPR screening identify new regulators of depolarization? | Genome-wide CRISPR library screening in hiPSC-derived cardiomyocytes |
How to Study the membrane depolarization during cardiac muscle cell action potential Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Ion currents (INa, ICa,L) and action potentials | Quantify depolarization kinetics in wild-type vs mutant cardiomyocytes |
| Optical mapping | Action potential propagation and conduction velocity | Assess arrhythmia risk in hiPSC-derived cardiomyocyte monolayers |
| Calcium imaging | Intracellular calcium transients | Study excitation-contraction coupling and alternans |
| CRISPR knockout screening | Gene essentiality for depolarization phenotypes | Identify novel regulators of action potential |
| RNA sequencing | Transcriptomic changes in ion channel genes | Evaluate electrical remodeling in disease models |
| Western blot | Protein expression of ion channels | Validate knockout or overexpression efficiency |
| Immunofluorescence | Subcellular localization of channels | Assess trafficking defects (e.g., connexin-43) |
| Microelectrode array | Extracellular field potentials | High-throughput drug screening on cardiomyocytes |
Patch-clamp electrophysiology
Patch-clamp recordings in whole-cell or perforated configuration measure sodium and calcium currents underlying depolarization. This method provides direct quantification of current density, activation, and inactivation kinetics, and is considered the gold standard for studying ion channel function in cardiomyocytes.
Optical mapping and voltage-sensitive dyes
Optical mapping using voltage-sensitive dyes allows non-invasive measurement of action potential propagation and depolarization timing in multicellular preparations or hiPSC-derived cardiomyocyte monolayers. This technique is useful for assessing conduction velocity and arrhythmia inducibility.
Calcium imaging
Calcium imaging with fluorescent indicators (e.g., Fluo-4) measures intracellular calcium transients that are triggered by depolarization. It is used to study excitation-contraction coupling and calcium alternans.
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens in hiPSC-derived cardiomyocytes can identify genes that regulate depolarization and action potential parameters. These screens combine gene editing with high-throughput phenotyping, such as voltage or calcium imaging.
How CRISPR Can Be Used to Study GO:0086012 membrane depolarization during cardiac muscle cell action potential
Knockout
CRISPR knockout of genes such as SCN5A or CACNA1C in hiPSC-derived cardiomyocytes can abolish or reduce depolarization currents, allowing researchers to test their necessity. Knockout models are also used in genome-wide screens to identify novel regulators of the action potential.
Point Mutation
Introducing patient-specific point mutations (e.g., in SCN5A or CACNA1C) via CRISPR base editing or homology-directed repair creates isogenic models to study how single amino acid changes alter channel gating and depolarization. These models are valuable for genotype-phenotype correlation.
Knock-in
Knock-in of reporter tags (e.g., fluorescent proteins) or disease alleles allows real-time tracking of channel trafficking and function. For example, tagging endogenous SCN5A can reveal its localization and turnover in cardiomyocytes.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can increase expression of ion channels or regulatory proteins to test sufficiency in driving depolarization changes. Overexpression of microRNAs or FGF13 can reveal their modulatory roles.
How EDITGENE Supports membrane depolarization during cardiac muscle cell action potential Research
Researchers studying membrane depolarization during cardiac muscle cell action potential-related genes often need to determine whether a candidate gene is causally involved in the upstroke, how a specific variant alters channel function, or which genes regulate the process. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for membrane depolarization during cardiac muscle cell action potential research.
Frequently Asked Questions About membrane depolarization during cardiac muscle cell action potential
What is membrane depolarization during cardiac muscle cell action potential?
It is the biological process (GO:0086012) in which the cardiac muscle cell membrane potential rapidly rises from its negative resting value toward the positive peak of the action potential, primarily due to sodium and calcium influx.
What genes are involved in membrane depolarization during cardiac muscle cell action potential?
Key genes include SCN5A (Nav1.5), CACNA1C (Cav1.2), CACNB2, and regulatory factors such as FGF13 and GJA1.
Why is membrane depolarization important for heart function?
It triggers calcium entry and excitation-contraction coupling, enabling the heart to contract and pump blood effectively.
What diseases are associated with defects in cardiac depolarization?
Arrhythmias such as Brugada syndrome, long QT syndrome, atrial fibrillation, and conduction defects are linked to abnormal depolarization.
How do researchers study membrane depolarization in cardiomyocytes?
Patch-clamp electrophysiology, optical mapping, calcium imaging, and CRISPR-based screens are commonly used.
What is the role of calcium in membrane depolarization?
L-type calcium current contributes to the upstroke in some cells and triggers calcium-induced calcium release from the sarcoplasmic reticulum.
Can microRNAs regulate cardiac action potential depolarization?
Yes, microRNAs can directly bind to ion channels and biophysically modulate the action potential.
What is mechano-electric feedback in the heart?
It is the modulation of cardiac electrical activity by mechanical stretch, which can influence depolarization and contribute to arrhythmias.
How does FGF13 affect cardiac impulse propagation?
FGF13 regulates connexin-43 trafficking, thereby influencing impulse propagation independently of voltage-gated sodium channels.
What CRISPR models are available for studying depolarization genes?
Knockout, point mutation, knock-in, and overexpression models in hiPSC-derived cardiomyocytes can be generated to dissect gene function.
Conclusion
GO:0086012, membrane depolarization during cardiac muscle cell action potential, is a cornerstone of cardiac electrophysiology. Its precise regulation by ion channels, calcium signaling, and non-canonical modulators ensures normal heart rhythm and contractility. Disruption of this process leads to a spectrum of arrhythmias and channelopathies, making it a critical area for therapeutic development. Advances in CRISPR gene editing and hiPSC-derived cardiomyocyte models now allow researchers to causally link genetic variants to depolarization phenotypes, accelerating the discovery of new targets and drugs.
References
- 1. Seibertz F et al.. 2023. Atrial fibrillation-associated electrical remodelling in human induced pluripotent stem cell-derived atrial cardiomyocytes: a novel pathway for antiarrhythmic therapy development.. Cardiovasc Res 119(16):2623-2637 PMID: 37677054
- 2. Gilbert G et al.. 2020. Calcium Signaling in Cardiomyocyte Function.. Cold Spring Harb Perspect Biol 12(3) PMID: 31308143
- 3. Das LT et al.. 2025. FGF13 Regulates VGSC-Independent Cardiomyocyte Impulse Propagation via Cx43 Trafficking.. Circ Res 137(12):1522-1539 PMID: 41200819
- 4. Edwards JN et al.. 2014. Cardiac alternans and intracellular calcium cycling.. Clin Exp Pharmacol Physiol 41(7):524-32 PMID: 25040398
- 5. Benitah JP et al.. 2010. L-type Ca(2+) current in ventricular cardiomyocytes.. J Mol Cell Cardiol 48(1):26-36 PMID: 19660468
- 6. Ravens U. 2003. Mechano-electric feedback and arrhythmias.. Prog Biophys Mol Biol 82(1-3):255-66 PMID: 12732284
- 7. Varró A et al.. 1992. The impact of single cell voltage clamp on the understanding of the cardiac ventricular action potential.. Cardioscience 3(3):131-44 PMID: 1384746
- 8. Yang D et al.. 2021. MicroRNA Biophysically Modulates Cardiac Action Potential by Direct Binding to Ion Channel.. Circulation 143(16):1597-1613 PMID: 33590773
